Piper Sandler Downgrades Apyx Medical Corp. (APYX) to Neutral
Tweet
Share
E-mailGet Alerts APYX Hot Sheet
Price: $3.11 +2.64%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien downgraded Apyx Medical Corp. (NASDAQ: APYX) from Overweight to Neutral with a price target of $2.00.
For an analyst ratings summary and ratings history on Apyx Medical Corp. click here. For more ratings news on Apyx Medical Corp. click here.
Shares of Apyx Medical Corp. closed at $2.07 yesterday.
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
- CJS Securities Downgrades Varex Imaging (VREX) to Market Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
